ESC 365 - Long-term TAVI durability - What do we know so far?

ESC Premium Access

Long-term TAVI durability - What do we know so far?

Session: Aortic stenosis treatment evolution – Which therapy for which patient?

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor D. Capodanno (Catania, IT)

Sponsored by Medtronic

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Davide Capodanno

University of Catania, Catania (Italy)

33 presentations

23 followers

5 more presentations in this session

Session objectives and introduction: the disparity of TAVI adoption across Europe

Speaker: Professor A. Baumbach (London, GB)

Multi-modality imaging for diagnosis of aortic stenosis and patient selection for TAVI

Speaker: Doctor V. Delgado (Barcelona, ES)

Update on TAVI evidence and latest clinical trials – Quality of life sub analysis

Speaker: Doctor D. Tchetche (Toulouse, FR)

The modern heart team approach - Case-based decision making

Speaker: Professor S. Bleiziffer (Bad Oeynhausen, DE) Professor T. Rudolph (Bad Oeynhausen, DE)

Conclusion and key learnings

Speaker: Professor F. Maisano (Milan, IT)

Access the full session

Aortic stenosis treatment evolution – Which therapy for which patient?

Speakers: Professor D. Capodanno, Professor A. Baumbach, Doctor V. Delgado, Doctor D. Tchetche, Professor S. Bleiziffer...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources